355 related articles for article (PubMed ID: 10395696)
1. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
[TBL] [Abstract][Full Text] [Related]
2. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
Thrane AS; Skehan JD; Thrane PS
Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
[TBL] [Abstract][Full Text] [Related]
3. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
[TBL] [Abstract][Full Text] [Related]
4. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
[TBL] [Abstract][Full Text] [Related]
5. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
[TBL] [Abstract][Full Text] [Related]
6. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.
Strachan AJ; Woodruff TM; Haaima G; Fairlie DP; Taylor SM
J Immunol; 2000 Jun; 164(12):6560-5. PubMed ID: 10843715
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Fc receptor type I for IgG on macrophages and complement mediate the inflammatory response in immune complex peritonitis.
Heller T; Gessner JE; Schmidt RE; Klos A; Bautsch W; Köhl J
J Immunol; 1999 May; 162(10):5657-61. PubMed ID: 10229794
[TBL] [Abstract][Full Text] [Related]
9. Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor.
Höpken UE; Lu B; Gerard NP; Gerard C
J Exp Med; 1997 Aug; 186(5):749-56. PubMed ID: 9271590
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine.
Arumugam TV; Shiels IA; Woodruff TM; Reid RC; Fairlie DP; Taylor SM
J Surg Res; 2002 Apr; 103(2):260-7. PubMed ID: 11922743
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.
Finch AM; Wong AK; Paczkowski NJ; Wadi SK; Craik DJ; Fairlie DP; Taylor SM
J Med Chem; 1999 Jun; 42(11):1965-74. PubMed ID: 10354404
[TBL] [Abstract][Full Text] [Related]
12. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
[TBL] [Abstract][Full Text] [Related]
13. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis.
Mullaly SC; Kubes P
Eur J Immunol; 2007 Jan; 37(1):224-34. PubMed ID: 17154261
[TBL] [Abstract][Full Text] [Related]
14. Protection of innate immunity by C5aR antagonist in septic mice.
Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
[TBL] [Abstract][Full Text] [Related]
15. Receptor activation by human C5a des Arg74 but not intact C5a is dependent on an interaction between Glu199 of the receptor and Lys68 of the ligand.
Crass T; Bautsch W; Cain SA; Pease JE; Monk PN
Biochemistry; 1999 Jul; 38(30):9712-7. PubMed ID: 10423250
[TBL] [Abstract][Full Text] [Related]
16. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
Shushakova N; Skokowa J; Schulman J; Baumann U; Zwirner J; Schmidt RE; Gessner JE
J Clin Invest; 2002 Dec; 110(12):1823-30. PubMed ID: 12488432
[TBL] [Abstract][Full Text] [Related]
17. Gαi2 is the essential Gαi protein in immune complex-induced lung disease.
Wiege K; Ali SR; Gewecke B; Novakovic A; Konrad FM; Pexa K; Beer-Hammer S; Reutershan J; Piekorz RP; Schmidt RE; Nürnberg B; Gessner JE
J Immunol; 2013 Jan; 190(1):324-33. PubMed ID: 23225882
[TBL] [Abstract][Full Text] [Related]
18. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
19. Human T cells express the C5a receptor and are chemoattracted to C5a.
Nataf S; Davoust N; Ames RS; Barnum SR
J Immunol; 1999 Apr; 162(7):4018-23. PubMed ID: 10201923
[TBL] [Abstract][Full Text] [Related]
20. On the role of complement and Fc gamma-receptors in the Arthus reaction.
Köhl J; Gessner JE
Mol Immunol; 1999; 36(13-14):893-903. PubMed ID: 10698344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
